Privacy Statement

Updated May 12, 2006

Allergan respects your privacy and recognizes your need for appropriate protection and management of personally identifiable information you share with us (the phrases “personally identifiable information” means any information by which you can be identified, such as your name, address, telephone number, etc.). The purpose of this privacy statement is to inform you what personally identifiable information we may collect from you when you visit our Site, and how we use such information, and the choices you have regarding our use of, and your ability to review and correct, the information. As we may revise our privacy policies from time to time, you should therefore periodically visit this page to review the then current Privacy Statement.

How We Collect Information

In general, you can visit many of our Web pages without telling us who you are or revealing any personally identifiable information. We may track the Internet domain address from which people visit us and analyze this data for trends and statistics, but individual users will remain anonymous, unless you voluntarily tell us who you are.

There may be times at which we ask you to provide certain information about yourself, such as your name, address, telephone number, e-mail address, etc. Whether or not to provide such information is completely your own choice; Allergan collects only the personal information that you provide to us. But if you choose not to provide the information we request, you may be unable to access certain services, offers, and content on our Site.

Cookies

To enable Allergan to provide customized and personalized services, Allergan may use cookies to store and sometimes track information about you. A cookie is a small amount of data that is sent to your browser from a Web server and stored on your computer. Cookies, by themselves, do not tell us any personally identifiable information about you. However, if you choose to furnish the Site with personally identifiable information (such as your e-mail address), that information could be linked to the data stored in the cookie. Allergan reserves the right to change our use of cookies and our practices regarding linkage to personally identifiable information without any prior notification.

How We Use Information We Collect

We use the information we automatically receive from your Web browser to see which pages you visit within our Site. We can then develop statistics that are helpful to understanding how this Site is used by our visitors. This statistical data is interpreted by Allergan in its continuing effort to present the Site content that visitors are seeking in a format they find most helpful.

When Allergan receives personally identifiable information, we may use it for reasonable business purposes, such as contacting you, via e-mail or regular mail, to provide you with information we believe may be of interest. If you e-mail us, you are voluntarily releasing information to us. Your e-mail address will be used by Allergan to respond to you.

Third-Party Use of Information

Allergan will not sell, share, or otherwise distribute your personally identifiable information to third parties except as provided herein. However, personally identifiable information may occasionally be transferred to third parties who act for or on behalf of Allergan, or in connection with the business of Allergan, for further processing in accordance with the purposes for which the data was originally collected. Your identity and the information you provide may be shared with your doctor. It will only be shared with your doctor if you have indicated to us that you would like to receive the quarterly e-mail newsletter and/or that you would like to receive future e-mail communications about Allergan products, programs, and services. Where disclosure of personally identifiable information to a third party is likely or necessary, further explanation may be provided, where appropriate, at such collection points as to the intended use of the data. We require that such third parties protect the information and, where appropriate, we will contractually require them to process data transferred only for the purposes expressly authorized by Allergan.

Because of the nature of the Internet, we may transmit the information to another country, but within Allergan, for purposes other than direct marketing, such as for storage, or because of where our servers are located. We may also use it to investigate security breaches or cooperate with authorities pursuant to a legal matter. We may also remove all the personally identifiable information and use the rest for historical, statistical, or scientific purposes. This Site contains links to other sites. Be aware that Allergan is not responsible for the privacy practices of non-Allergan sites. We encourage you to review the privacy statements of any Web sites that you visit through a link on this Site.

Children

In order to respect the privacy of children online, we do not knowingly collect, maintain, or process personal information submitted by children under the age of 13. If you have a child under the age of 13 who you believe may have provided information to us, please e-mail us at corpinfo@allergan.com and we shall expeditiously delete it.

BOTOX® Cosmetic Important Information

Indication

BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in people 18 to 65 years of age for a short period of time (temporary).

IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING

BOTOX® Cosmetic may cause serious side effects that can be life threatening. Call your doctor or get medical help right away if you have any of these problems any time (hours to weeks) after injection of BOTOX® Cosmetic:

Problems swallowing, speaking, or breathing, due to weakening of associated muscles,can be severe and result in loss of life. You are at the highest risk if these problems are pre-existing before injection. Swallowing problems may last for several months.
Spread of toxin effects. The effect of botulinum toxin may affect areas away from the injection site and cause serious symptoms including: loss of strength and all-over muscle weakness, double vision, blurred vision and drooping eyelids, hoarseness or change or loss of voice (dysphonia), trouble saying words clearly (dysarthria), loss of bladder control, trouble breathing, trouble swallowing.

There has not been a confirmed serious case of spread of toxin effect when BOTOX® Cosmetic has been used at the recommended dose to treat frown lines.

Do not take BOTOX® Cosmetic if you: are allergic to any of the ingredients in BOTOX® Cosmetic (see Medication Guide for ingredients); had an allergic reaction to any other botulinum toxin product such as Myobloc® or Dysport ® have a skin infection at the planned injection site.

Tell your doctor about all your muscle or nerve conditions such as amyotrophic lateral sclerosis [ALS or Lou Gehrig's disease], myasthenia gravis or Lambert-Eaton syndrome as you may be at increased risk of serious side effects including severe dysphagia (difficulty swallowing) and respiratory compromise (difficulty breathing) from typical doses of BOTOX® Cosmetic.

Tell your doctor about all your medical conditions, including if you have: plans to have surgery; had surgery on your face; weakness of forehead muscles, such as trouble raising your eyebrows; drooping eyelids; any other abnormal facial change; are pregnant or plan to become pregnant (It is not known if BOTOX® Cosmetic can harm your unborn baby); are breast-feeding or plan to breastfeed (It is not known if BOTOX® Cosmetic passes into breast milk).

Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins and herbal products.

BOTOX® Cosmetic may cause loss of strength or general muscle weakness, or vision problems. If this happens, do not drive a car, operate machinery, or do other dangerous activities.

Other side effects of BOTOX® Cosmetic include: dry mouth, discomfort or pain at the injection site, tiredness, headache, neck pain, and eye problems: double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of your eyelids, and dry eyes.

For more information refer to the Medication Guide or talk with your doctor.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see BOTOX® Cosmetic full Product Information, including Medication Guide.

JUVÉDERM® Safety Information

*JUVÉDERM® is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).

Important JUVÉDERM® Safety Information

JUVÉDERM® injectable gel (including JUVÉDERM® Ultra, JUVÉDERM® Ultra Plus, JUVÉDERM® Ultra XC, and JUVÉDERM® Ultra Plus XC) is indicated for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Side effects were usually mild to moderate, lasting 7 days or less, and included temporary injection-site reactions such as redness, pain, firmness, swelling, and bumps. JUVÉDERM® is not for people with severe allergies. For more information, please click on the About Safety link at www.juvederm.com or call the Allergan Product Support line at 1-877-345-5372. JUVÉDERM® injectable gel is available by prescription only.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

BotoxCosmetic.com | Juvederm.com | Privacy Statement | Contact Allergan